Search research articles
Contact Us
Filters
Showing results (211-220 of 242) with videos related to
Page
of 25
Sort By:
The Journal of Prevention of Alzheimer'S Disease
|
January 25, 2026
Potential role of MRI to optimize clinical trial design for progressive supranuclear palsy and corticobasal degeneration
Jesús García-Castro, Lawren VandeVrede, Michael C Donohue, et al.
Genome Medicine
|
October 4, 2023
Multivariate GWAS of Alzheimer's disease CSF biomarker profiles implies GRIN2D in synaptic functioning
Alexander Neumann, Olena Ohlei, Fahri Küçükali, et al.
Alzheimer'S & Dementia (New York, N. Y.)
|
January 1, 2020
A metabolite-based machine learning approach to diagnose Alzheimer-type dementia in blood: Results from the European Medical Information Framework for Alzheimer disease biomarker discovery cohort
Daniel Stamate, Min Kim, Petroula Proitsi, et al.
Neurobiology of Aging
|
June 22, 2015
Validation of a quantitative cerebrospinal fluid alpha-synuclein assay in a European-wide interlaboratory study
Niels Kruse, Staffan Persson, Daniel Alcolea, et al.
Neurobiology of Aging
|
May 9, 2017
The frequency and influence of dementia risk factors in prodromal Alzheimer's disease
Isabelle Bos, Stephanie J Vos, Lutz Frölich, et al.
Nature Medicine
|
January 6, 2026
A minimally invasive dried blood spot biomarker test for the detection of Alzheimer's disease pathology
Hanna Huber, Laia Montoliu-Gaya, Wagner S Brum, et al.
Biomedicines
|
November 27, 2021
Sex-Specific Metabolic Pathways Were Associated with Alzheimer's Disease (AD) Endophenotypes in the European Medical Information Framework for AD Multimodal Biomarker Discovery Cohort
Jin Xu, Rebecca Green, Min Kim, et al.
JAMA Network Open
|
January 22, 2025
Cerebral Microbleeds and Amyloid Pathology Estimates From the Amyloid Biomarker Study
Julie E Oomens, Veerle van Gils, Stephanie J B Vos, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
September 10, 2019
Discovery and validation of plasma proteomic biomarkers relating to brain amyloid burden by SOMAscan assay
Liu Shi, Sarah Westwood, Alison L Baird, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
June 17, 2025
The Down Alzheimer Barcelona Neuroimaging Initiative (DABNI) and its contributions to understanding Alzheimer's disease in Down syndrome: A decade of discovery
Laura Videla, Bessy Benejam, Isabel Barroeta, et al.
Page
of 25
Search research articles
Search
Showing results (211-220 of 242) with videos related to
Sort By:
Page
of 25
The Journal of Prevention of Alzheimer'S Disease
|
January 25, 2026
Potential role of MRI to optimize clinical trial design for progressive supranuclear palsy and corticobasal degeneration
Jesús García-Castro, Lawren VandeVrede, Michael C Donohue, et al.
Genome Medicine
|
October 4, 2023
Multivariate GWAS of Alzheimer's disease CSF biomarker profiles implies GRIN2D in synaptic functioning
Alexander Neumann, Olena Ohlei, Fahri Küçükali, et al.
Alzheimer'S & Dementia (New York, N. Y.)
|
January 1, 2020
A metabolite-based machine learning approach to diagnose Alzheimer-type dementia in blood: Results from the European Medical Information Framework for Alzheimer disease biomarker discovery cohort
Daniel Stamate, Min Kim, Petroula Proitsi, et al.
Neurobiology of Aging
|
June 22, 2015
Validation of a quantitative cerebrospinal fluid alpha-synuclein assay in a European-wide interlaboratory study
Niels Kruse, Staffan Persson, Daniel Alcolea, et al.
Neurobiology of Aging
|
May 9, 2017
The frequency and influence of dementia risk factors in prodromal Alzheimer's disease
Isabelle Bos, Stephanie J Vos, Lutz Frölich, et al.
Nature Medicine
|
January 6, 2026
A minimally invasive dried blood spot biomarker test for the detection of Alzheimer's disease pathology
Hanna Huber, Laia Montoliu-Gaya, Wagner S Brum, et al.
Biomedicines
|
November 27, 2021
Sex-Specific Metabolic Pathways Were Associated with Alzheimer's Disease (AD) Endophenotypes in the European Medical Information Framework for AD Multimodal Biomarker Discovery Cohort
Jin Xu, Rebecca Green, Min Kim, et al.
JAMA Network Open
|
January 22, 2025
Cerebral Microbleeds and Amyloid Pathology Estimates From the Amyloid Biomarker Study
Julie E Oomens, Veerle van Gils, Stephanie J B Vos, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
September 10, 2019
Discovery and validation of plasma proteomic biomarkers relating to brain amyloid burden by SOMAscan assay
Liu Shi, Sarah Westwood, Alison L Baird, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
June 17, 2025
The Down Alzheimer Barcelona Neuroimaging Initiative (DABNI) and its contributions to understanding Alzheimer's disease in Down syndrome: A decade of discovery
Laura Videla, Bessy Benejam, Isabel Barroeta, et al.
Page
of 25